Financial Sponsors Interview Questions

What does a financial sponsors group do inside an investment bank?

A financial sponsors group owns the bank's relationship with financial sponsors: private equity firms and other professional investors that buy, finance, hold and sell companies across every industry. It is a coverage group, not a product group, so its job is to know the client and bring in the right specialists each time the sponsor needs something.

In practice the work follows the life of an investment:

- Buying: acquisition ideas, a view of what the sponsor can afford to pay, and buy-side advice. - Financing: making the case for the bank to commit to the buyout debt, which leveraged finance then structures and syndicates. - Holding: refinancings, repricings, add-on financings and dividend recaps for portfolio companies. - Exiting: framing the sale, IPO or other exit options and competing for the mandate.

Because a sponsor transacts constantly, the group is judged on its wallet share across all of that work rather than on any single deal. How much of the execution it runs itself, as opposed to handing it to M&A, leveraged finance or capital markets teams, varies by bank.

Walk me through a sponsor's investment from the first pitch to the exit. Where does the bank earn fees along the way?

A single investment can pay the bank at every stage: advice and financing at entry, a run of smaller mandates during the hold, and sell-side or IPO fees at the exit.

1. Pitch: the coverage banker brings the sponsor an idea or flags an asset coming to market. There is no fee yet; this is the investment in the relationship. 2. Bid: on larger or more complex deals, such as take-privates and carve-outs, the sponsor may hire the bank as buy-side adviser and pay an advisory fee. 3. Financing: before signing, banks commit to fund the debt and then syndicate it, earning arrangement and underwriting fees. On a large buyout this is often the biggest fee at entry. 4. Hold: over several years the portfolio company refinances or reprices its loans, raises incremental debt for add-ons and may pay a dividend recap, and the bank also earns on its revolver and hedging. 5. Exit: a sell-side advisory fee on a sale to a strategic buyer or another sponsor, or underwriting fees on an IPO and the later sell-downs. If another sponsor buys, its acquisition financing is a new fee.

That is why the coverage banker stays with the client after each deal closes. The bank that financed the purchase and worked through the hold knows the company best when the exit comes, although sponsors still invite several banks to pitch for the sale.

Three sponsors your bank covers want to bid for the same company, and your M&A team is advising the seller. What conflicts does that create, and how does the bank manage them?

The bank's duty runs to the client that hired it, the seller, and its relationships with the bidders pull against that duty in three ways.

1. Divided loyalty: the seller wants the highest, most certain price, while the coverage team wants to stay close to sponsors that are some of the bank's biggest fee payers. The risk is that the bank tilts the process toward the bidder it knows best. 2. Financing fees: financing a bidder can pay as much as the sell-side fee, which gives the bank a stake in who wins and on what terms. 3. Information: the sell-side team holds the seller's confidential data and every bidder's offer. Nothing can pass to a colleague working with one of the bidders.

The bank manages this through conflict clearance before it accepts the sell-side mandate, full disclosure of its relationships to the seller, and information barriers between the sell-side team and anyone financing a buyer. If the seller allows the bank to finance bidders, it usually uses separate financing teams for each and offers the same terms to all, often as a staple package. Bankers working with the bidders are kept behind the barrier, and the bank generally takes no buy-side advisory role on that deal. On a public target, the board may also bring in an unconflicted second adviser.

Barriers manage the conflict but do not remove it, which is why the seller's consent and the disclosure of fees matter so much.

How is a financial sponsors group different from an industry group, leveraged finance and M&A, and who does what on a sponsor deal?

They are built on two different axes. FSG and industry groups are coverage groups that own client relationships, while leveraged finance and M&A are product groups that own a transaction skill. On a sponsor deal each owns a different decision:

- FSG owns the client: which fund is investing, how much capital it has left, its return hurdle and appetite for leverage, and the commercial call on how much balance sheet the relationship justifies. It is judged on wallet share across products and years. - The industry group owns the target: the company's competitive position, sector valuations, precedent deals and the list of likely buyers, including the strategic bidders it covers as clients. - Leveraged finance owns the debt: it sizes and structures the package, takes it through credit approval, then syndicates it to investors, carrying the underwriting risk if markets move. - M&A owns the process: valuation work, bid strategy and negotiation on the buy side, or running the auction on the sell side, paid mostly when the deal closes.

The groups need one another: FSG knows the buyer but not the sector, and leveraged finance can fund the bid but needs someone to judge whether the client is worth the risk. The split varies by bank. At a boutique, the sponsors banker is often also the M&A banker, and at a middle-market bank the FSG team may run execution itself.

A sponsor buys a company for $2 billion with $1.2 billion of debt and sells it three years later for the same $2 billion. Your bank was its buy-side adviser (0.5% fee), lead arranger on the debt (2% fee) and sell-side adviser (1% fee). What did the bank earn, and why does that not depend on the sponsor's return?

The bank earns about $54 million, even though the sponsor sold for exactly what it paid.

- Buy-side advice: 0.5% x $2 billion = $10 million - Arranging the debt: 2% x $1.2 billion = $24 million - Sell-side advice: 1% x $2 billion = $20 million

Total: $10 million + $24 million + $20 million = $54 million, before anything earned during the hold, such as the revolver, hedging or a refinancing. If the buyer at the exit is another sponsor, its acquisition financing is a further fee.

None of it depends on the sponsor's return, because banking fees are paid on transaction size and completion, not on the investor's profit. That is the core of why sponsors are such valuable clients: a sponsor transacts at entry, through the hold and at exit, so the bank is paid for activity. The link to performance is indirect but real: a sponsor that keeps losing money raises smaller funds and does fewer deals, and the financing fee comes with underwriting risk if the debt cannot be sold.

What is relationship lending, and why do sponsors steer advisory and capital markets roles toward the banks that lend to them?

Relationship lending is lending on thin terms, such as an undrawn revolver or a large acquisition commitment, in order to win the fee-paying business that comes with being one of a client's lenders.

Sponsors reward lenders for three reasons:

1. Debt is essential: a buyout cannot be signed without committed financing, so the banks that provide it are doing the work the sponsor values most. 2. Risk the sponsor remembers: a bank that holds a revolver earning almost nothing, or keeps its commitment when markets turn, has supported the sponsor when it mattered. The sponsor's head of capital markets keeps a ledger of who delivered. 3. The natural shortlist: the lenders already know the company's numbers and documents, so they are the obvious candidates for its refinancing, IPO and sale roles.

The link has limits. A loan reliably wins more lending, but it earns a seat rather than the lead on advisory work. Sponsors often hand out joint titles while concentrating the economics, and they pick the sell-side adviser on judgment and buyer access, because that choice sets the exit price. In the US a bank also cannot make a loan conditional on getting an advisory mandate; it can only earn the mandate.

What is a financial sponsor, and how do buyout funds, growth investors, infrastructure funds, credit managers, family offices and sovereign wealth funds differ as bank clients?

A financial sponsor is an investor that buys and sells companies with professionally managed capital, as opposed to a strategic buyer that acquires businesses to combine with its own operations. The types differ less in size than in three things: how long their capital can stay invested, how much debt they use, and who decides which banks to hire.

- Buyout funds: closed-end funds with a roughly ten-year life, control stakes and as much debt as lenders allow. They buy the most from a bank: acquisition financing, buy-side and sell-side advice, refinancings and IPOs. - Growth investors: mostly minority stakes in fast-growing companies with little or no debt, so the bank earns mainly at the exit, often through an IPO or a sale. - Infrastructure funds: lower target returns, long holds and long-dated debt at the asset level, so they buy asset financing, hedging and advice on large stakes. - Credit managers: they lend rather than borrow, so they compete with the bank for loans, partner with it on others, and occasionally end up owning companies. - Family offices, sovereign wealth funds and pensions: permanent capital with no fund deadline and moderate leverage. They want deal access, co-investment alongside sponsors and advice on direct deals, and they sell less often.

The pattern for a coverage banker is that the further a client sits from the classic buyout fund, the less it needs the bank's balance sheet and the more it values advice and access.

Why can a large alternative asset manager be a bank's client, co-lender and competitor at the same time?

Because the largest managers are no longer just buyout funds. Most now run large credit businesses, many manage insurance money, and several own broker-dealers, so the same firm meets the bank in three roles.

- Client: its buyout funds still need underwritten acquisition financing, advice on take-privates, IPOs and sale processes, and they are some of the largest fee payers a bank has. - Co-lender: its credit funds and insurance accounts join lender groups, take pieces of loans the bank arranges, or partner with the bank on direct lending, and the bank may lend to its funds through fund finance. - Competitor: its credit arm bids against the bank's syndicated offer with a private loan it holds itself, and its capital markets desk takes arranger titles and part of the fee on the firm's own deals and sometimes on other sponsors' deals. It can even pitch the bank's investment grade corporate clients a structured equity or joint venture investment in place of a bond.

The coverage banker therefore has to know which business is across the table on each deal: the buyout team wanting the most debt, the credit team wanting to hold the loan, or the desk wanting the fee. The bank wins where it adds something the firm cannot do alone, such as a large underwritten commitment, distribution, sector knowledge or independent advice.

How does a growth equity investment differ from a buyout, and what does that mean for the fees a bank can earn from a growth investor?

The difference is the source of the return. A buyout buys control of a mature business with a lot of debt, so its return comes from earnings growth, debt paydown and the exit multiple. A growth equity investor usually buys a minority stake, often as convertible preferred stock, in a fast-growing company with little or no debt, so its return comes almost entirely from the company getting bigger.

That changes the bank's economics:

- Little at entry: with no acquisition debt there is no underwritten loan, which is the largest fee on a buyout. The bank may earn a placement fee on a large private round or advise the company. - Most fees at the exit: an IPO and the sell-downs after it, a sale to a strategic buyer, or a sale to a buyout sponsor, which brings the company's first acquisition financing. - Shared decisions: a minority investor cannot pick the sell-side bank alone. The founder and the board have a say in the route, timing and adviser, so the industry banker who knows the founder often matters as much as the sponsors banker.

A growth investor protects itself through contract rather than control: a liquidation preference, protective provisions that give it vetoes, a board seat and registration rights. A coverage banker has to know which of those holders must consent before a sale or listing can happen.

Investor A buys $50 million of existing shares in a company valued at $500 million. Investor B instead puts $100 million of new money into the same company at a $400 million pre-money valuation. What stake does each get, and what happens to the company's equity value and enterprise value in each case?

Investor A gets 10% and Investor B gets 20%, and in both cases enterprise value is unchanged. The difference is where the money goes.

- Investor A (secondary): it pays $50 million to existing shareholders for 10% of a company valued at $500 million ($50 million / $500 million). No money enters the company, so its equity value stays at $500 million and enterprise value does not move. Only the shareholder list changes. - Investor B (primary): it invests $100 million of new money at a $400 million pre-money valuation, so the post-money valuation is $500 million and its stake is $100 million / $500 million = 20%. Equity value rises from $400 million to $500 million, but the company now holds $100 million more cash. Enterprise value is equity value less net cash, so it is unchanged.

The point for a growth deal is that primary capital strengthens the balance sheet and funds expansion, while secondary capital only gives liquidity to founders and early holders. Many growth rounds mix the two, so the split tells you whether the company is raising money to grow or its shareholders are cashing out.

How do infrastructure funds differ from buyout funds in return targets, holding periods and use of debt, and what work do they bring a bank?

Infrastructure funds accept lower returns for steadier cash flows, hold for longer and borrow differently, so they buy different things from a bank.

- Return targets: core strategies, such as regulated utilities and contracted power, target roughly 6% to 9% net, and core-plus about 9% to 12%. A buyout fund typically underwrites to 20% or more gross. Much of a core return comes from cash yield, not from a sale. - Holding periods: often seven years or more, and core money frequently sits in open-ended funds with no end date, so many assets are not sold on a fund clock. - Debt: substantial but long-dated, raised mostly at the operating company in investment grade bonds or private placements. Any extra leverage sits in a holding company above it, which is structurally subordinated. The financing looks more like project or investment grade debt than a buyout loan. - Deal shape: they are willing to take minority stakes or joint venture interests beside a strong operator.

So the work for a bank is different. Corporates selling a stake in a utility or carving out a network create sell-side and buy-side mandates; the debt work is private placements, bonds, project finance and hedging rather than a term loan B; and deals close on the regulator's timetable, with approval conditions that become part of the price. The higher-risk value-add and opportunistic strategies behave more like buyout funds and do need an exit.

How does a sovereign wealth fund or a large pension investing directly differ from a buyout fund as a client, and what changes when it moves from co-investing to leading a deal?

Their capital has no fund deadline and no outside fees to pay, and that changes both how they invest and what they buy from a bank.

A buyout fund must buy, improve and sell within a fund life of about ten years, uses as much debt as lenders allow, and pays the bank at every stage. A sovereign wealth fund or a large pension invests its own or its beneficiaries' money, can hold an asset for as long as the case lasts, usually uses more moderate leverage, and answers to an investment committee and a board, sometimes with a policy mandate next to the return target. Investing directly also saves the management fee and carried interest it would pay as a fund investor.

The bank's role depends on where the institution sits on the spectrum:

- Co-investor: it takes a minority slice of a deal led by a sponsor, often at low or no fees, with no board seat. The lead sponsor picks the banks, so the bank mainly offers deal access. - Co-sponsor: it joins the bidding group, shares governance and diligence, approves the financing and takes board seats, so it has a real say in the advisers and lenders. - Lead or sole buyer: it behaves like a sponsor, hiring its own buy-side adviser, raising underwritten acquisition debt, dealing with foreign investment regulators and eventually selling.

The same institution can be a passive co-investor on one deal and the lead on the next, so the coverage banker treats it as a client in its own right, not only as an investor in other sponsors' funds.

What is a locked-box mechanism, and why do sponsor sellers usually prefer it to completion accounts?

A locked-box mechanism fixes the purchase price on a balance sheet dated before signing, the locked-box date. The seller promises that no value leaks out of the company between that date and closing, through dividends, fees or other payments to the seller, and there is no adjustment after closing. Under completion accounts, the price is set on an estimate and then trued up after closing for the actual net debt and working capital on the closing date.

Sponsor sellers usually prefer the locked box because:

- Price certainty: the fund knows exactly what it will receive when it signs. - Immediate distribution: there is no later adjustment that could claw money back, so the fund can return cash to its investors and close out the investment. - No post-closing disputes: completion accounts can lead to months of argument over the closing balance sheet. - The seller can be paid for the cash the business generates after the locked-box date, typically through a negotiated daily ticker added to the price, even though the cash itself stays in the company for the buyer.

The buyer takes the economic risk of the business from the locked-box date and has to do more financial diligence before signing, so it relies on the locked-box accounts and on the leakage protection. Some payments to the seller are agreed in advance as permitted leakage, such as an agreed monitoring fee or pay to seller-appointed directors, so a locked box limits leakage rather than banning it. Locked boxes are the norm in European sponsor deals, while US deals more often use completion adjustments.

How is a private equity fund structured, and how does a deal team get the capital to do a deal?

A private equity fund is usually a limited partnership. The limited partners (LPs), such as pensions, endowments, sovereign wealth funds, insurers and family offices, commit capital. The general partner (GP), the sponsor's entity, manages the fund, makes the investment decisions and puts in a small commitment of its own.

The money is not handed over on day one. LPs make a commitment, and the GP calls it as it needs it:

1. During the investment period, usually about five or six years inside a fund term of around ten, the deal team sources and works up new platform investments. 2. Each deal goes through the firm's investment committee, typically once before a first-round bid and again before a binding offer, which approves the price, the financing and the equity check. 3. At signing, the fund commits the equity to a newly formed acquisition vehicle, and at closing it calls capital from the LPs, often bridging the call for a few months with a subscription credit line. 4. The rest of the purchase price is debt raised by the acquisition vehicle and secured on the target, not borrowed by the fund itself.

If a deal is too large for one fund's concentration limits, the sponsor brings in co-investors, often its own LPs, or partners with other sponsors. After the investment period, the fund can usually call capital only for add-ons to existing companies, fees and expenses, so new platforms move to the successor fund.

How does a private equity firm make money, and how do management fees and carried interest shape what it does with its funds?

A private equity firm earns money in three ways, and each one pushes its behavior in a different direction:

- Management fees: LPs pay roughly 1.5% to 2% a year on committed capital during the investment period, then usually on invested capital. Fees grow with fund size, which pushes the firm to raise larger funds and to deploy them before the investment period ends, when uncalled capital stops earning and can no longer buy new platforms. - Carried interest: usually 20% of the fund's profits, paid only after LPs get their capital back plus a preferred return, commonly 8% a year. Carry rewards realized gains, so it largely decides when a sponsor sells, and LPs judge the next fundraise on the cash the current funds return. - Portfolio-company fees: transaction, monitoring and director fees paid by the companies themselves. Today most fund agreements offset them fully against the management fee, so they matter less as income but still leave the company.

The behavior follows from that mix. Near the end of the investment period a sponsor may stretch on price to finish deploying. Once a fund is past its hurdle, the sponsor may hold a winner longer for more carry dollars, even at a lower IRR. When the next fundraise is close, it wants realizations to show cash returned. Knowing which of these pressures applies to a given fund is what lets a banker anticipate the sponsor's next request.

What are dry powder and DPI, and how does each one push a sponsor toward different kinds of deals?

Dry powder is the capital a fund has raised but not yet called. DPI, distributions to paid-in capital, is the cash a fund has returned to its LPs divided by the capital they have paid in. They act as two clocks running in opposite directions, usually in different funds of the same sponsor.

Dry powder creates deployment pressure. A fund with a lot of uncalled capital and little time left in its investment period widens what it will consider:

- bigger bids, more leverage or a less proven asset - take-privates and carve-outs, where one signing absorbs a large equity check - large add-ons to existing platforms - minority and structured equity investments that deploy capital without needing control

Low DPI creates distribution pressure. LPs judge the next fundraise largely on the cash the older funds have returned, so a fund with strong marks but little cash back reaches for:

- sales of companies that will clear at or near their marks - partial sales and minority stakes, and sell-downs after an IPO - dividend recaps - fund-level liquidity, such as NAV loans and continuation vehicles

The same firm can be an aggressive buyer through its newest fund and a motivated seller through an older one in the same month. One point is often missed: distribution pressure rarely puts the weakest companies up for sale, because selling below the mark hurts the track record the next raise depends on.

Walk me through an LBO.

In an LBO, a sponsor buys a company using a large amount of debt, with the company's own cash flow repaying that debt, and sells it after a few years. The return comes from the equity it puts in growing faster than the business itself, because the debt shrinks while the company's value holds or grows.

1. Entry assumptions: the purchase price, usually a multiple of EBITDA, and how it is funded. Lenders typically provide a large share as debt and the sponsor contributes the rest as equity. 2. Sources and uses: debt and sponsor equity, plus any management rollover, fund the purchase of the shares, the refinancing of existing debt and the transaction and financing fees. 3. Projections: forecast EBITDA and free cash flow over the hold, after interest, taxes, capex and working capital. 4. Debt paydown: cash flow repays debt each year, through scheduled amortization and any cash sweep. 5. Exit and returns: value the company at an exit multiple, subtract the remaining net debt to get the equity value, and compare it with the equity invested to get the MOIC and the IRR.

The returns come from three sources: EBITDA growth, debt paydown and any change in the exit multiple. A sponsor uses the same logic in reverse when it bids, starting from the return it needs and working back to the most it can pay.

What makes a company a good LBO candidate?

A good LBO candidate can carry a lot of debt safely and still grow its equity value. The main traits:

- Stable, predictable cash flow: recurring or contracted revenue and low cyclicality, so the company can pay interest in a downturn. - Strong cash conversion: low capex and modest working capital needs, so EBITDA turns into cash that repays debt. - A defensible market position: pricing power and barriers to entry that protect margins. - Room to improve: cost savings, pricing, add-on acquisitions or a better capital structure that the sponsor can act on. - A capable management team, or one the sponsor can strengthen, willing to invest alongside it. - Assets or cash flows lenders can rely on, which support more and cheaper debt. - A reasonable price and a clear exit: paying too much is the most common way an LBO fails, and the sponsor needs credible future buyers or an IPO path.

The poor candidates are the reverse: highly cyclical or capital-intensive businesses, companies burning cash, and anything bought at a price that only works if the exit multiple goes up.

What returns does a buyout fund typically underwrite a new deal to, and why is that hurdle higher than the fund's preferred return?

Buyout funds typically underwrite a new deal to a gross IRR of roughly 20% to 25% and a multiple of about 2.0x to 3.0x, with 2.5x over five years a common reference point. The exact bar moves with the risk of the business and the fund's strategy: a defensive asset may clear at less, a cyclical one needs more, and infrastructure funds work to much lower targets.

The hurdle sits well above the fund's preferred return, usually 8%, for two reasons:

Fees and carry come out of the gross return. LPs are judged on net returns, after management fees, fund expenses and the general partner's carry. That gap is commonly around five percentage points a year, so a deal earning 15% gross would leave LPs with little more than they could earn in public equities, without the liquidity.

The preferred return is a floor, not a target. It only decides when the general partner starts to share in profits. A deal that earned 8% gross would give LPs a mid single-digit net return after fees and the sponsor no carry at all.

A sponsor also needs some deals to beat the hurdle by a wide margin, because a fund's return has to absorb the investments that disappoint.

Why might a sponsor choose a deal with a lower IRR but a higher MOIC?

Because IRR measures speed while MOIC measures dollars, and a sponsor is ultimately paid in dollars.

Take two options: 2.0x in two years, an IRR of about 41%, or 3.0x in six years, about 20%. The first has the higher IRR, but the second returns twice the profit on the same equity.

A sponsor can prefer the higher multiple for several reasons:

- Carry: once a fund is past its hurdle, the general partner earns roughly 20% of every extra dollar of gain, so a larger gain means more carry, even if it takes longer. - Redeployment cost: cash returned early has to find a new deal, which takes time, sourcing costs and fees, and may earn less. - What LPs watch: a fast flip with a small profit barely moves a fund's multiple, and many LPs now weigh how many dollars came back as much as how quickly. - Flattered IRRs: early dividend recaps or fund-level borrowing raise IRR without creating any extra value.

The trade-off has limits. A sponsor still needs to clear its IRR hurdle, and when the fund is short of distributions or the next fundraise is close, a quick exit at a lower multiple can be the better choice.

Walk me through how a sponsor's investment committee approves a deal during an auction.

The deal goes through staged approvals that track the seller's auction timetable, each one committing more money and more of the sponsor's credibility.

1. Screening: after the teaser and confidentiality agreement, the deal team asks whether the asset fits the fund's strategy and size limits and deserves a diligence budget. 2. Preliminary IC: before the first-round bid, the committee approves an indicative price range, the leverage assumed and spending on outside advisers. 3. Confirmatory diligence: in the second round, the team meets management, works through the data room and adviser reports, and runs a lender process to firm up the financing. 4. Final IC: before the binding bid, the committee approves the final price, the equity commitment and the financing, usually backed by lenders' commitment papers. Some firms add a final check before closing.

The committee is made up of the firm's senior partners, and the deal team presents a written IC memo: the thesis, the base, downside and upside returns cases, the value creation plan, sources and uses and lender terms, diligence findings and risks, and the exit assumptions. If the equity check is too large for one fund's concentration limits, the approval also covers co-investors or a consortium. Once the committee has approved a number, going higher usually needs a new approval, which is why sellers try to move the price before the final IC meets.

A sponsor buys a company with $40 million of EBITDA at 10x, funded with 5.0x debt and the rest in equity. Over five years EBITDA grows to $60 million and the company repays $100 million of debt; the sponsor exits at 10x. What are the MOIC and the IRR?

The MOIC is 2.5x and the IRR is about 20%.

- Entry: 10 x $40 million = $400 million, funded with 5.0 x $40 million = $200 million of debt and $200 million of equity. - Exit: 10 x $60 million = $600 million of enterprise value, less $100 million of remaining debt ($200 million - $100 million), leaves $500 million of equity. - Returns: $500 million / $200 million = 2.5x over five years, which is roughly a 20% IRR.

Since the multiple did not change, the $300 million of equity gain came from two sources: $200 million from EBITDA growth ($20 million more EBITDA at 10x) and $100 million from debt paydown.

A sponsor needs 2.5x its money over five years. The target earns $80 million of EBITDA, expected to reach $120 million by the exit; lenders will provide 4.0x entry EBITDA, $200 million of that debt will be repaid, and the sponsor assumes it exits at the same multiple it pays. Ignoring fees, what is the most it can pay?

The most it can pay is 8.5x, or $680 million.

Because the exit multiple equals the entry multiple, the quickest route is to try a couple of multiples:

- At 8x: price $640 million, debt $320 million, equity $320 million. Exit at 8 x $120 million = $960 million, less $120 million of remaining debt = $840 million, about 2.6x. Too much return, so the sponsor can pay more. - At 9x: price $720 million, equity $400 million. Exit $1,080 million less $120 million = $960 million, 2.4x. Too little.

So the answer sits between them. Solving exactly, with M as the multiple: exit equity of 120M - 120 must equal 2.5 x (80M - 320), so 120M - 120 = 200M - 800, which gives M = 8.5x. Check: price $680 million, equity $360 million; exit value $1,020 million less $120 million of debt = $900 million, which is exactly 2.5x.

This is the ability-to-pay logic a sponsor and its banker use before an auction. The sponsor works back from the return it needs to the highest price it can bid, and any change in leverage, cash generation, timing or exit multiple moves that ceiling.

A sponsor client's model does not reach its target return on a company it wants to win. What could it change, and what would you suggest as its banker?

The sponsor has a handful of levers, and as its banker I would focus on the ones that change the economics rather than just the spreadsheet.

1. Price: bid lower and accept a higher risk of losing, or change how the price is paid, through an earn-out, a seller note or more management rollover. 2. Financing: look for more or cheaper debt, for example by testing the syndicated market against private credit or pushing lenders to credit more of the add-backs. Extra leverage helps less than it seems, because the extra interest reduces debt paydown and adds risk. 3. The plan: add-ons, cost savings or synergies with a portfolio company it already owns, which let it bid more like a strategic buyer, but only if the investment committee will believe them. 4. Partners: bring in co-investors to cut its own check, which eases concentration limits and risk without changing the return on each dollar invested, or a structured equity partner, which works like extra leverage: it can lift the sponsor's return per dollar but takes a senior, fixed claim on the upside. 5. The hurdle: a fund under pressure to deploy may accept a slightly lower return for a high-quality asset.

What I would steer it away from is assuming a higher exit multiple or a shorter hold just to make the numbers work. If the gap only closes that way, the honest advice is that the price is too high, and a good coverage banker says so before the final committee rather than after a retrade.

What is the difference between a platform and an add-on, and why do sponsors pursue buy-and-build strategies?

A platform is the first company a sponsor buys in a sector, approved by the fund's investment committee and paid for with fund equity and new acquisition debt. An add-on is a smaller business the platform then buys, usually with its own cash flow and borrowing capacity, and often from a founder or family rather than through an auction.

Sponsors pursue buy-and-build strategies for four reasons:

- Multiple arbitrage: small companies sell at lower multiples than larger ones. Earnings bought cheaply are worth the platform's higher multiple when the combined company is sold. - Synergies: cost savings, cross-selling and better purchasing make each add-on worth more inside the platform than on its own. - Scale and quality: a larger, more diversified company attracts more buyers and lenders at the exit. - Deploying capital efficiently: add-ons are funded with a mix of the platform's debt capacity and follow-on equity, so a fund can keep putting money to work in a business it already knows, even after it stops buying new platforms.

The catch is that the arbitrage is earned only if the add-ons are properly integrated. An exit buyer pays the platform multiple for one company running on one set of systems, not for a collection of small businesses, and each add-on bought on that assumption adds debt in the meantime.

A sponsor buys a platform with $50 million of EBITDA at 12x, then three add-ons with $25 million of EBITDA in total at 6x. What is its blended entry multiple, and how much value does multiple arbitrage create if a buyer pays 12x for the combined company?

The blended entry multiple is 10.0x, and multiple arbitrage alone creates $150 million.

- Platform: 12 x $50 million = $600 million - Add-ons: 6 x $25 million = $150 million - Blended entry multiple: $750 million / $75 million = 10.0x - Value at exit: 12 x $75 million = $900 million, against $750 million paid, so $150 million of gain with no growth at all

That gain depends on the buyer paying 12x for all the earnings. If the add-ons are not integrated and a buyer values their earnings at only 6x, the company is worth $600 million + $150 million = $750 million, and the arbitrage disappears. That is why investment committees test integration and the exit multiple so hard in a buy-and-build.

What drives returns in an LBO, and which of those levers can a sponsor actually control?

Returns in an LBO come from three drivers:

1. EBITDA growth: higher revenue and better margins, organically or through add-ons, raise the value of the business at a constant multiple. 2. Debt paydown: free cash flow repays debt, so more of the enterprise value belongs to the equity at exit. 3. Multiple expansion: selling at a higher multiple than the one paid.

A fourth lever is set at entry: the price and the leverage. Paying less, or funding more of the price with debt, reduces the equity check and magnifies the return, although more debt also raises the risk.

The sponsor controls these levers to very different degrees:

- Largely controllable: the entry price it agrees to, the capital structure, cost and pricing programs, working capital, add-ons and the management team. These drive EBITDA growth and cash generation, and through them debt paydown. - Partly controllable: growth, which also depends on the market, and the timing of the exit. - Largely outside its control: the exit multiple, which depends on market conditions and buyers' appetite when the company is sold.

That is why investment committees prefer plans that work at an exit multiple no higher than the entry multiple. A deal whose return depends on multiple expansion is a bet on the market, not on the sponsor's own work.

How do private equity firms source deals, and what does a "proprietary" deal really mean?

Sponsors find deals through two broad routes: processes run by sellers' banks and channels they build themselves.

Bank-run processes: broad auctions, where many buyers bid to one timetable, and limited processes with a few invited buyers. This is where the largest deals are usually sold, and the seller's bank decides who gets invited.

Sponsor-led channels: a sector thesis that maps a niche and calls owners for years, often around founder succession; introductions from executives, operating partners, lenders, accountants and lawyers; private company databases; and approaches to listed companies or corporations with non-core units.

A sponsor's own coverage bank helps in both: it flags which processes are coming and what financing to expect, shares sector theses, makes introductions and carries reverse inquiries, where the sponsor asks the bank to approach a specific company.

"Proprietary" is the loosest word in the industry. Sponsors use it for anything that was not a full auction: a deal they found themselves, a short exclusive window, a head start, or a relationship with management. It describes how the conversation started, not how the price was set. A founder with an adviser, a corporate seller with a board, or a listed company whose directors owe duties to shareholders will usually test an approach against other buyers before signing, so many "proprietary" deals end as small competitive processes.

What is a pre-emptive bid, and why would a seller accept one?

A pre-emptive bid is an offer made before or early in a sale process, at a price high enough to persuade the seller to stop the process and negotiate exclusively with one bidder for a short, fixed period.

A seller accepts one when it values price and certainty more than the extra tension a full auction might create:

- the price is credibly above what the seller's bank expects the auction to produce - the bidder can sign quickly, with committed financing and most diligence already done - a shorter process means less disruption for management and less risk of a leak or a market change - the bidder looks unlikely to cut the price later in diligence

The seller's bank protects its client by testing the offer, often by sounding a few other buyers quickly, and by holding the bidder to a tight exclusivity period so the process can restart if the price slips. For the sponsor, a pre-empt pays for time and the removal of rivals, which only works if it has done much of its homework before the process starts.

A listed company's share price has fallen sharply, but you think the business is sound. How would you pitch it to a sponsor as a take-private idea?

I would build the pitch around five questions: why the stock is cheap, why this sponsor, what it can pay, why the board would engage now, and how the deal would get done.

1. Why it is cheap: show that the fall reflects something temporary or fixable, such as a missed quarter or a sector sell-off, not a broken business. Compare its valuation with peers and its own history. 2. Why this sponsor: check the fit with the fund's mandate (sector, size, region) and that the equity check fits its concentration limits, possibly with co-investors. Show the value creation plan, such as cost work, add-ons or the sale of a non-core unit, which is often easier to execute out of public view. 3. What it can pay: run an ability-to-pay analysis. The sponsor has to offer a premium the board can recommend to shareholders, measured against the undisturbed share price, and still reach its target return with the debt lenders will provide. If the numbers only work without a premium, the idea is not actionable. 4. Why the board might engage: look for signs that the board is open to offers, such as an activist stake, a strategic review, large holders who want liquidity or a founder thinking about succession. 5. How it would get done: a likely special committee if insiders are involved, the market check the board will need, and the committed financing the bank can provide, plus any conflicts that limit the bank's role.

The bank's angle is usually the financing and its read of the board. An idea with fit and a price but no reason for the board to act is a screen, not a pitch.

Why do private equity firms hire banks as buy-side advisers when they have their own deal teams?

Because a sponsor's deal team can model, diligence and negotiate, but there are things it cannot do or see from inside its own bid. A bank adds value in four ways:

1. Process intelligence: it covers the seller, the rival bidders and their lenders, so it can read the contest: what the seller needs, who else is likely to bid, what their financing lets them pay, and how much each raise needs to be. 2. Complex deal mechanics: take-privates, cross-border bids, carve-outs and consortium bids involve offer structure, board approaches, regulators and filings, and in the UK a cash confirmation, which a sponsor's team does not handle every day. 3. Financing: an adviser that can also commit debt strengthens the bid and its certainty. Financing is often the main reason a sponsor hires a bank at all, and the advisory role can be the reward for committing. 4. Coordination and judgment: keeping lenders, accountants, consultants and lawyers on the seller's timetable, and giving an outside view on when a bid is enough.

The adviser does not set the price, which stays with the sponsor's investment committee. That is why sponsors hire buy-side advisers mainly for public, contested or complex deals and often buy add-ons with no adviser at all.

What is the difference between a sponsor's indication of interest and its final binding bid?

An indication of interest (IOI) is a non-binding first-round letter. It gives a price or price range, the basis for it (for a private company, usually enterprise value on a cash-free, debt-free basis with normal working capital), the assumptions behind it, how the sponsor plans to finance the deal, the diligence it still needs and the approvals it requires. The seller uses IOIs to choose who goes into the second round.

The final binding bid comes after full diligence and is meant to be signable:

- a firm price, not a range - a mark-up of the seller's draft purchase agreement - financing evidence: debt commitment letters from lenders and an equity commitment letter from the fund - final investment committee approval and a short list of any remaining conditions - a timetable to sign

The practical difference for a seller is credibility. Sponsors often stretch their IOI range to reach the second round, so the bottom of the range is the real number. A final bid is judged on price and certainty together, so a slightly lower bid with committed financing and a clean contract can beat a higher one with open conditions.

Walk me through a sell-side auction from the point of view of a sponsor bidder.

From a sponsor bidder's seat, an auction is a series of decisions about how much time, money and credibility to commit at each stage.

1. Teaser and NDA: the sponsor decides whether the asset fits its fund and signs a confidentiality agreement, which usually bars it from teaming with other bidders and limits how it shares information with lenders (for example by requiring consent or banning exclusive lender arrangements). 2. CIM and first round: it reads the confidential information memorandum and the seller's model, builds a quick returns case, sounds out lenders and sends an IOI approved at a preliminary investment committee. 3. Second round: if invited, it gets management meetings, the data room and vendor reports, hires accountants, consultants and lawyers, and runs a lender process, often against a staple offered by the seller. 4. Final bid: after final investment committee approval, it submits a binding price with a contract mark-up, committed debt and an equity commitment letter. Along the way it may ask for exclusivity, sketch a management incentive plan or try to pre-empt. 5. Signing and closing: the winner negotiates final documents, signs and works through regulatory approvals and the financing to closing.

The sponsor's main lever is certainty: committed financing, a clean mark-up and a short timetable. The seller's main defense is keeping at least two bidders engaged until the final price is set, because a bidder that knows it is alone has no reason to raise and every diligence finding becomes a reason to retrade.

Strategic buyers can usually pay more because of synergies. How can a sponsor still win an auction against one?

By offering things a strategic buyer often cannot, so that its bid is better on a risk-adjusted basis even if it is lower on paper.

- Certainty: committed debt, an equity commitment from the fund and few conditions. A strategic bid may face a long antitrust review, a vote of its own shareholders or a share price that has to hold until closing. - Speed: a sponsor can often sign in weeks with a short confirmatory diligence list. - A cleaner regulatory path: a fund with no overlapping business usually faces a lighter antitrust review. - Scope: a sponsor will buy the whole company when strategic buyers only want one division, sparing the seller a break-up. - Management: a continuing role and equity for the team, which an integrating buyer may not offer. - A clean contract: a mark-up close to the seller's draft, with few changes to risk allocation. - Its own synergies: bidding through a portfolio company in the same industry lets a sponsor count combination savings and bid closer to a strategic price.

Sell-side bankers compare bids as price and certainty together. A strategic offer a few percent higher that carries a real risk of being blocked or delayed can be worth less to a seller than a lower sponsor bid it can sign this week.

In a US take-private, when does the target need a special committee, and what does a majority-of-the-minority condition add?

A special committee is needed when someone on the buyer's side is connected to the company, so the board can no longer negotiate at arm's length. Typical triggers in a sponsor take-private:

- management will roll over equity or keep their jobs, so they are negotiating with the buyer while advising the seller - the sponsor already owns a stake or has directors on the board - a controlling or large shareholder rolls its shares or joins the buyer group - directors who work for a bidder or one of its portfolio companies

The conflicted directors step aside, and a committee of independent, disinterested directors takes over the negotiation with its own lawyers and bankers and the power to say no. Its approval is the main evidence that the price was negotiated fairly.

A majority-of-the-minority condition goes further: the deal closes only if a majority of the unaffiliated (disinterested) stockholders voting approve it, so the buyer's own votes cannot carry it, so the buyer's own votes cannot carry it. When the buyer is a controlling stockholder, Delaware law gives the deal deferential court review only if it has both an empowered independent committee and an informed majority-of-the-minority vote. Without both, the deal faces the much stricter entire fairness test.

For the sponsor, the minority vote is a real cost. It gives public holders, including funds that buy shares after the announcement to push for more, a veto, so the bid has to satisfy them as well as the committee.

What does "certain funds" mean in a UK take-private, and how does it change the way a sponsor's debt is committed?

"Certain funds" means the money must be certain before a UK bid is announced. Under the Takeover Code, a bidder can announce a firm offer only if it can pay in full, and for a cash offer an appropriate third party, usually the bidder's financial adviser, must publicly give a cash confirmation that the resources are available. Because the adviser is putting its name to that statement, it checks the equity and debt documents almost as closely as the lenders do.

That changes how the debt is committed:

- Lenders can only refuse to fund in a few extreme cases, such as the borrower's insolvency, a major misrepresentation or illegality. A weaker business, market disruption or unfinished diligence are not grounds to walk away. - The debt is committed before the announcement, usually in an interim facilities agreement: a short-form loan that could fund completion on its own and is later replaced by full facilities. - Lenders carry the risk until completion, which can take many months, so they protect themselves through flex terms and fees rather than through conditions. - A locked-in bidder: once the firm offer is announced, it can usually let the offer lapse only with the Takeover Panel's consent.

So in a UK take-private the financing has to be committed before the firm offer is announced; if the bidder has already been named, that usually means inside the 28-day put-up-or-shut-up deadline, which the target can ask the Panel to extend. In a US deal, a sponsor typically signs with commitment letters and finalizes the debt over the following months.

A corporate division reports $120 million of segment EBITDA after a $10 million allocation of group overhead. Running on its own, it would need $25 million a year of new costs to replace the parent's services. What EBITDA should a sponsor and its lenders underwrite, and what does the difference mean at 10x and at 5x leverage?

The sponsor and lenders should underwrite $105 million of standalone EBITDA, not the $120 million the parent reports.

- Segment EBITDA: $120 million - Add back the group overhead allocation that stops at closing: +$10 million - Subtract the new costs of running alone (finance, IT, HR, insurance and so on): -$25 million - Pro forma standalone EBITDA: $105 million

The $15 million difference matters a lot once it is multiplied:

- At 10x: the business is worth $1,050 million, not $1,200 million, so $150 million less. - At 5x leverage: lenders will lend $525 million, not $600 million, so $75 million less debt, which the sponsor would have to fill with equity if the price were still based on the reported $120 million.

This is why carve-out diligence focuses on standalone costs and the transition services agreement. The parent's allocation records what it charged the unit, not what the unit will actually spend alone. One-off separation costs, such as new systems or hiring a finance team, sit outside EBITDA and have to be funded separately. Sponsors and lenders often agree on the cost lines but argue over how much credit to give planned savings that have not happened yet.

Why do sponsors bid together in clubs or sell co-investment to their LPs, and how does a club deal differ from a co-investment?

Sponsors bid together for three main reasons:

- Size: a fund's concentration limit caps how much it can put into one company, so a large deal can need more equity than one fund may write. - Risk sharing: a smaller check limits the loss if the deal goes wrong. - Capability: a partner can bring sector expertise, a local presence or, alongside a foreign buyer, a domestic investor that eases regulatory or political concerns.

A club deal joins two or more sponsors as near-equals. Each brings its own investment committee, shares the board seats and has a say in major decisions, so governance has to be negotiated between peers.

In a co-investment, one lead sponsor keeps control and outside investors, usually its own LPs or sovereign and pension investors, take passive minority stakes, often with reduced or no management fee and carry. Co-investors approve their own commitment but do not run the deal. Sponsors offer co-investment to cut their own check without giving up control and to reward their largest LPs, and they can sell it before signing or after closing.

For the bank, the difference decides who the client is. In a club each sponsor has its own coverage relationship and committee to satisfy; in a led deal the lead sponsor speaks for the group and usually chooses the advisers and lenders. Sellers control teaming through confidentiality agreements, because two leading bidders joining forces can remove competition.

A sponsor buys a debt-free, founder-owned company for $400 million, funded with $200 million of debt. The founder rolls $40 million of the proceeds. How much does the sponsor invest, what stakes do the two hold, and how much cash does the founder take home?

The sponsor invests $160 million, the sponsor owns 80% and the founder 20%, and the founder takes home $360 million in cash.

- Equity needed: $400 million price - $200 million of debt = $200 million - Founder's rollover: $40 million of that equity, so the sponsor writes the remaining $200 million - $40 million = $160 million - Ownership: $160 million / $200 million = 80% for the sponsor; $40 million / $200 million = 20% for the founder, assuming both buy the same securities at the same price - Founder's cash: $400 million - $40 million rolled = $360 million, before fees and taxes

Sponsors ask for rollover because a founder who keeps a meaningful stake is betting on the plan alongside them, and because it reduces the fund's equity check. For the founder, the rolled portion can often be structured to defer tax, while the cash part is taxed at closing. The rolled stake has no exit of its own: the founder usually can join a sale the sponsor starts through tag-along rights but cannot force one, so the value depends on the sponsor's exit decision.

How is the equity in a UK or European buyout typically split between the sponsor's institutional strip and management's sweet equity, and why?

The sponsor invests mainly through an institutional strip, and management gets sweet equity on top.

Institutional strip: the sponsor puts most of its money into preference shares or shareholder loan notes that accrue a fixed coupon, often around 10% to 12% a year, and only a small amount into ordinary shares. Managers who invest on the same terms, for example with their rollover, buy the same strip at the same price and earn the sponsor's return on that money.

Sweet equity: because the preference paper and its coupon are repaid first, the ordinary shares are worth little at closing. Management can buy a meaningful slice, often 10% to 20% of the ordinary equity, for a small amount of money.

The point is incentives. Managers cannot afford a large stake at the sponsor's price, so sweet equity gives them a leveraged share of the upside for little capital. It only pays off if the business grows beyond the value needed to repay the preference paper with its coupon, so the coupon works as management's hurdle. Sponsors often add a ratchet that increases management's share if the fund's return clears a target.

The structure also has a tax logic: managers pay full market value for low-value shares, which helps their gains be taxed as capital rather than as income. Leaver terms decide what managers who leave early keep.

A sponsor invests $400 million for all of a company's equity and sells it for $1 billion of equity value. Management holds a 10% incentive pool. What is the sponsor's MOIC with no pool, with a pool that shares in the full exit value, and with a pool that shares only in value above the $400 million entry value?

The sponsor's MOIC is 2.5x with no pool, 2.25x with a full-value pool and 2.35x with a pool above the entry value.

- No pool: $1,000 million / $400 million = 2.5x. - Pool shares in the full exit value: management takes 10% x $1,000 million = $100 million, the sponsor keeps $900 million, and $900 million / $400 million = 2.25x. - Pool shares only in value above the entry value of $400 million: the value created is $1,000 million - $400 million = $600 million, so management takes 10% x $600 million = $60 million. The sponsor keeps $940 million, which is 2.35x.

The design of the pool matters as much as its headline size. A pool with a threshold at the entry value pays management only for value created after the sponsor invested, which is how profits interests work in US deals. In UK deals the preference shares and their coupon do a similar job. As a result, the cost to the sponsor is well below 10% of the exit proceeds and rises as the exit value grows.

In a UK buyout the sponsor invests $90 million in total, mostly in loan notes with a small amount in ordinary shares, and ends up with 90% of the ordinary shares. Management pays $2 million for the other 10%. What is the envy ratio, and what does management make on its money if the ordinary shares are worth $300 million at exit?

The envy ratio is 5.0x, and management makes 15x its money.

- Sponsor's price per 1% of the ordinary shares: $90 million / 90 = $1.0 million - Management's price per 1%: $2 million / 10 = $0.2 million - Envy ratio: $1.0 million / $0.2 million = 5.0x. The sponsor pays five times as much per point of ordinary equity, because most of its money sits in loan notes ranking ahead.

At exit: if the ordinary shares are worth $300 million after the loan notes are repaid, management's 10% is worth $30 million on $2 million invested, or 15x. The sponsor's ordinary shares are worth $270 million, and it also gets its loan notes back with their coupon, so its overall multiple is much lower.

The envy ratio measures how generous the deal is to management. A higher ratio means management gets more upside per dollar invested. Sponsors keep it at a level that motivates the team without looking like disguised pay, because a very high ratio can draw tax challenges over whether managers paid a fair price for their shares.

A sponsor signs a deal through a newly formed company with no assets. How does the seller get comfort that the deal will actually close?

Through a set of side documents that turn the empty bidding company into a credible buyer:

1. Equity commitment letter: the fund commits to put a stated amount of equity into the bidding company at closing. The seller can usually only seek a court order that the equity be funded, not sue the fund for the price. 2. Debt commitment letters: banks or direct lenders commit to fund the debt on limited-conditionality terms, known in the US as SunGard terms. The lenders' conditions to funding are cut down to closely match the buyer's conditions to close under the merger agreement, plus a few specified representations largely within the buyer's control, so there is little room for the lenders to refuse to fund when the buyer is obliged to close. In the UK, the Takeover Code goes further and requires certain funds and a public cash confirmation. 3. Limited guarantee: the fund guarantees the bidding company's payments if the deal fails, chiefly the reverse termination fee, up to a cap. It is the seller's only direct money claim against the fund. 4. Remedies in the merger agreement: these decide whether the seller can force closing. The common hybrid is conditional specific performance: the seller can compel closing once the debt is available, and takes the reverse fee if the debt fails. A sponsor that commits enough equity to fund the whole price without the debt, a full equity backstop, removes the financing risk entirely.

The reverse fee for sponsor buyers of public companies is typically a few percent of deal value, and it caps the fund's exposure, so a seller is really relying on the lenders' signature. That is why the strength of a sponsor's financing commitments is part of the value of its bid.

What types of debt go into a typical LBO financing package, and how do they differ?

A typical package combines several layers, from the safest and cheapest to the riskiest and most expensive:

- Revolving credit facility: a working-capital line, usually undrawn at closing and provided by banks. For asset-heavy borrowers it can be an asset-based loan (ABL) sized on receivables and inventory. - Term loan A: an amortizing senior loan held by banks. It is less common in large buyouts. - Term loan B: the workhorse of large buyouts. It is senior secured, floating rate, sold to institutional investors such as CLOs, with minimal amortization (often 1% a year), a maturity of about seven years and usually covenant-lite terms. - Second lien loan: secured but ranking behind the first lien, at a higher margin. It adds quantum by layering risk. - High-yield bonds: fixed rate, secured or unsecured, with longer non-call periods and only incurrence covenants. - Unitranche: in the private credit market, one loan from a direct lender or a small club that blends senior and junior risk into a single price and document. - Mezzanine or holding company PIK debt: subordinated debt whose interest often accrues rather than being paid in cash. It is the most expensive layer below equity.

The layers differ in seniority, security, cost, amortization, covenants and call protection. A sponsor chooses the mix by starting from the asset's cash flow and collateral and from its own plans: how much debt it needs, how certain the financing must be, and how much flexibility it wants for add-ons, dividends or an early exit.

What goes into the sources and uses of funds for a buyout?

The sources and uses table shows where the money for a buyout comes from and where it goes, and the two sides must be equal.

Uses:

- Purchase of the equity: the price paid to the sellers, or the equity value for a public company - Refinancing of existing debt: the target's debt is usually repaid at closing because a change of control triggers repayment - Transaction costs: advisory, legal, accounting and diligence fees - Financing fees and any original issue discount on the new debt - Cash to the balance sheet, if the company needs a minimum level to operate

Sources:

- New debt: each tranche listed separately, such as the term loan, notes or unitranche (an undrawn revolver adds no cash) - Management rollover and any co-investors - Sponsor equity: usually the plug, the amount needed to balance the table after the debt is sized - sometimes cash already on the target's balance sheet or a seller note

The table matters because it shows the equity check, which drives the sponsor's return, and makes sure fees and debt refinancing are not forgotten in the price the sponsor has to fund.

Lender A offers 5.0x leverage on the target's reported EBITDA of $200 million. Lender B offers 4.5x on an adjusted EBITDA of $230 million that credits the sponsor's add-backs. Which raises more debt, and what should the sponsor check before choosing?

Lender B raises more: $1,035 million against $1,000 million, despite the lower multiple.

- Lender A: 5.0 x $200 million = $1,000 million - Lender B: 4.5 x $230 million = $1,035 million, which is about 5.2x the reported $200 million

Leverage multiples only compare on the same EBITDA, so before choosing the sponsor should check:

1. The quality of the add-backs: removing a genuine one-off cost is solid, while crediting synergies or savings not yet achieved is a forecast. Lender B is lending against $30 million of adjustments, part of which may be savings the company has not yet achieved. 2. The covenant definition: if Lender B tests a leverage covenant on the same adjusted figure, check the cushion if the savings arrive late. 3. The cost: compare margins, fees and original issue discount, since the bigger offer may deliver less cash after the discount and cost more interest every year. 4. Interest coverage on reported EBITDA: the company pays interest from real earnings, not adjusted ones. 5. Terms and certainty: conditions, flex, flexibility for add-ons and call protection.

The extra $35 million is worth having only if the add-backs are credible and the sponsor is not paying too much for the extra debt.

Why do sponsors use debt to buy companies, and can adding more leverage ever lower their returns?

Sponsors use debt because it magnifies the return on their equity. Paying for most of the price with borrowed money means a smaller equity check, so any increase in the company's value accrues to a smaller base. Debt is also cheaper than equity, interest is usually tax-deductible, and as the company's cash flow repays debt, more of the enterprise value belongs to the equity. Fixed debt service also imposes discipline on how the company uses cash.

More leverage can lower returns, in several ways:

- Expensive debt: if the interest on the extra debt exceeds the return the extra capital generates, adding leverage reduces equity returns. The last turn of debt is usually the most expensive. - Slower deleveraging: extra interest slows deleveraging, so the equity at exit grows less than the smaller check suggests. - Distress: a downturn can push a highly levered company into a covenant breach or a restructuring where the sponsor loses its equity. - Lost flexibility: less room for add-ons, investment or dividends can limit the value the sponsor creates.

So leverage raises the expected IRR up to a point, but it also widens the range of outcomes. Sponsors and lenders both test how much debt the business can carry in a downside case, not just in the plan.

How do you decide how much debt a buyout can carry, and which credit metrics do lenders look at?

Debt capacity comes from what lenders will accept on leverage, coverage and repayment, all tested on the lenders' own definition of EBITDA and under a downside case.

1. Leverage: total debt and senior secured debt as multiples of EBITDA, benchmarked against comparable recent financings and the lenders' appetite for the sector and the credit quality. 2. Interest coverage: EBITDA divided by cash interest. For example, with $100 million of EBITDA and a lender requiring at least 2.0x coverage, interest cannot exceed $50 million, so at an all-in rate of 10% debt is capped at $500 million, or 5.0x. At 8% the cap rises to $625 million, so the same business can carry more or less debt depending on the rate. 3. Free cash flow and repayment: whether the company generates enough cash after capex, working capital and taxes to service the debt and reduce leverage meaningfully over the hold. 4. Downside resilience: whether coverage and covenants still hold if EBITDA falls or rates rise. 5. Collateral: receivables, inventory or other assets that can support an asset-based facility or improve recoveries.

The main credit metrics are total and net leverage (debt / EBITDA), senior secured leverage, interest coverage (EBITDA / interest), fixed charge coverage (which also counts capex and other fixed payments) and free cash flow to debt. Capacity is usually set by whichever test binds first, which is often coverage when rates are high and leverage when rates are low.

What is the difference between maintenance and incurrence covenants, and why do sponsors push for incurrence-only terms?

A maintenance covenant is tested regularly, usually every quarter, whatever the company does. A typical example is a maximum net leverage ratio. Breaching it is a default even if the company has taken no new action. Maintenance tests are standard in bank term loans, revolvers and much of the private credit market.

An incurrence covenant is tested only when the company takes a specific action, such as raising new debt, paying a dividend or making an acquisition. If the company is above the ratio, it simply cannot take that action, but it is not in default. High-yield bonds use only incurrence covenants, and most syndicated term loans are now covenant-lite, with at most a springing maintenance test on the revolver that applies only when it is drawn above a threshold.

Sponsors push for incurrence-only terms because:

- A temporary dip in EBITDA does not trigger a default, so they avoid paying lenders fees, wider margins or extra equity for an amendment - They keep flexibility for add-ons, dividends and investment without asking permission - Lenders lose leverage over the company when things go wrong

Lenders accept this mainly when competition for loans is strong. The cost to them is less early warning and a weaker position in a downturn, which tends to mean lower recoveries. Where a maintenance test remains, sponsors negotiate a wide cushion and an equity cure, which lets the sponsor inject equity that counts toward the test.

How does a sponsor compare competing debt financing offers for a buyout?

I would put every offer on one basis and then rank them on what this sponsor cares about most for this deal. Sponsors usually weigh five things: quantum, cost, certainty, flexibility and speed, plus portability and who the lenders are.

1. Restate the EBITDA: record what each lender credits as covenant EBITDA, because a lower multiple on a bigger adjusted figure can raise more money. 2. Convert the cost: calculate the all-in yield including original issue discount and fees, the cash received after the discount and the annual cash interest. 3. Stress the covenants: run each lender's tests on its own definition under a downside case and compare the cushions. 4. Map flexibility to the plan: incremental capacity, most favored nation protection, dividend and investment baskets, and portability against planned add-ons, recaps and the exit. 5. Weigh certainty and timing: conditions, market flex, how fast each lender can commit, and whether the lender holds the loan or needs to syndicate it. 6. Price the way out: call protection and prepayment premiums decide what it costs to reprice or refinance later.

The ranking then depends on the situation. In a contested auction or take-private, certainty and speed lead, so a direct lender's final terms can be worth a wider spread. For a buy-and-build platform, flexibility leads. For a stable business in an open market, cost and quantum usually win. The cheapest offer is not always best, and the biggest offer often buys its last turn of debt at a high price.

Two lenders offer a term loan for the same buyout: one at SOFR + 325 basis points issued at 99, the other at SOFR + 300 issued at 97.5. Assuming the loan is outstanding about four years, which is cheaper for the borrower?

The first offer is cheaper: about 350 basis points a year against about 363.

The original issue discount (OID) is part of the cost, because the borrower receives less than face value but repays it in full. Spreading the discount over the assumed life gives a rough all-in spread:

- Offer 1: 325 bp + (1 point of OID / 4 years = 25 bp) = 350 bp - Offer 2: 300 bp + (2.5 points / 4 years, about 62.5 bp) = about 363 bp

So the loan with the lower headline margin costs the borrower about 12.5 bp more a year. The market convention is to spread OID over three years, which gives about 358 bp against 383 bp and makes the gap wider, so the answer does not change.

Before choosing, the sponsor would also compare the floor on the base rate, other upfront fees, the cash actually received at closing, call protection, covenants and how certain each offer is.

Beyond price and leverage, which terms in a buyout credit agreement does a sponsor fight hardest for, and why do lenders resist them?

The terms sponsors fight hardest for are the ones that decide what the company can do after closing without asking its lenders.

- Incremental debt capacity: a free-and-clear amount the company can borrow under the same agreement without meeting a test, plus more as long as leverage stays below a ratio. This funds add-ons. - A loose most favored nation clause: a wide pricing cushion or a short sunset, so new debt does not force the existing margin up. - Restricted payments and investment baskets: room to pay dividends to the sponsor and to move money or assets around the group. - A generous EBITDA definition: add-backs for synergies and cost savings with high caps, which increase debt capacity and covenant room. - Covenant-lite terms, or a wide cushion with an equity cure. - Portability, so the debt can stay in place when the company is sold. - Short call protection, so the company can reprice cheaply when the credit improves.

Lenders resist because the same freedom can be used against them when the company struggles. Baskets and unrestricted subsidiaries have let distressed companies move valuable assets out of the lenders' collateral, and loose provisions have allowed new debt to rank ahead of existing lenders through liability management transactions. Generous add-backs inflate leverage capacity. Lenders now ask for protective clauses that block those moves, and the negotiation is a trade between the sponsor's need for flexibility and the lenders' need to keep their claim on the business.

Walk me through how a bank commits to and syndicates a buyout loan. How do underwritten, best-efforts and club financings differ?

When a sponsor signs a buyout without a financing condition, the arranging banks usually give an underwritten commitment and then sell most of the debt to investors.

1. Structuring: leveraged finance designs the package, and the capital markets desk says where the loans and bonds would sell and which investors have room for them. 2. Approval: a commitment committee approves the size, pricing, the flex the bank needs and the amount it expects to keep, its hold level. The coverage banker argues the relationship case. 3. Commitment papers: at signing, the banks sign a commitment letter with term sheets and conditions, and a private fee letter setting out fees and market flex. 4. Syndication: the banks launch the loan to institutional investors such as CLOs and loan funds, build a book, adjust pricing within the flex caps if needed, and allocate. Bonds are usually backed by a bridge loan until they can be issued. 5. Funding: at closing the banks fund whatever has not been sold and keep their hold, usually a small slice of the term loan and a larger share of the revolver.

The three structures differ in who carries the debt investors do not buy:

- Underwritten: the banks promise the full amount and carry any unsold debt, which is why sponsors need it to sign without a financing condition. - Best efforts: the banks only promise to try, so if investors do not buy, the deal shrinks or fails. - Club: a few lenders agree their shares in advance and each holds its piece, so there is no syndication risk.

What is market flex, and why do arranging banks insist on it?

Market flex is a right, set out in the fee letter, that lets the arranging banks change the terms of an underwritten financing within agreed caps if they need to in order to sell it. It can mean a higher margin, a deeper original issue discount, moving debt between tranches, or tighter terms such as smaller baskets or stronger call protection.

Banks insist on it because they commit weeks or months before they can sell the debt. Without flex, they would have to quote terms safe enough for a bad market, which would make their offer uncompetitive. With flex, they can quote close to today's market and keep the right to adjust if investors push back. The caps become the real price of the commitment: if investors demand more than the caps allow, the excess comes out of the banks' own fees, and in a bad enough market the banks can lose money.

For the sponsor, flex is the cost of certainty. A fully flexed loan means higher interest for years and possibly less cash at closing, so the sponsor negotiates the caps as hard as the opening margin and must make sure that even flexed debt still raises enough to close. It also works the other way: when demand is strong, sponsors push for reverse flex, meaning a lower margin, a smaller discount or a larger loan.

Why does a bank decide whether to underwrite a sponsor's buyout financing on its own case rather than on the sponsor's model?

Because the bank is lending its own balance sheet and has to be able to sell the debt, while the sponsor's model is built to win the deal.

- Different incentives: the sponsor's case supports the price it wants to pay and assumes its plan works. The bank's case asks whether the company can service the debt if the plan slips. - The bank carries the risk until syndication and keeps a hold position afterwards, so its credit approval rests on a downside case: lower growth, savings that come late, higher rates. - Investors' own view: loan and bond buyers will scrutinize the add-backs and projections, and a bank that underwrites on an optimistic case may not be able to sell the debt within its flex caps. - Regulation and internal policy often require an independent assessment of leverage and of any adjustments to EBITDA, made by people outside the deal team. - Its reputation with investors depends on bringing deals that perform.

In practice, the bank's case credits fewer add-backs, assumes slower growth and tests whether coverage and covenant headroom survive a downturn. The gap between the two cases is where the negotiation on leverage, pricing, flex and covenants happens, and the coverage banker's job is to make sure the sponsor understands it before the bid, not after.

What is staple financing, why would a sponsor seller ask its bank for one, and what conflict can it create?

Staple financing is a debt package that the seller's bank arranges in advance and offers to every bidder in a sale process. It can range from indicative term sheets to a full commitment, and some are now provided by direct lenders that will hold the loan.

A sponsor seller asks for one because it supports the price:

- It sets a leverage benchmark, so every bidder knows at least one lender will fund a stated amount on stated terms. - Weaker bidders stay in: A sponsor without lenders who know the sector can still bid, which forces the strongest bidder to pay more. - It speeds up the process, because lenders do much of their diligence before final bids. - It adds certainty in volatile markets, when the syndicated market might not be reliable.

Winners often replace the staple with cheaper financing from their own lenders, but it still sets a floor.

The conflict is that the seller's adviser is supposed to get the best price and terms for the seller, while the staple lets it earn financing fees from the buyer, which can be several times its advisory fee. That gives it an incentive to favor bidders that will use its financing. Sellers manage this through board consent to any buy-side role, separate teams, a second adviser with no financing role, and full disclosure of the financing fees. A staple offered openly to all bidders is part of the auction; a financing role negotiated privately with one bidder is a side deal.

A sponsor picks a direct lender over your bank's syndicated financing offer. How can the bank still earn money on the deal and stay close to the account?

Losing the term loan rarely means losing the whole financing, and a bank has several ways to stay on the account:

- The revolver: most buyouts still need a revolving credit facility, and many direct lenders prefer not to hold large undrawn commitments. A bank can provide it beside the unitranche, often as a super-senior revolver that is repaid first from collateral. That keeps the bank in the lender group. - Ancillary business: the revolver usually brings cash management, hedging of interest rates and currencies, and letters of credit. - Partnerships and its own balance sheet: if the bank has an origination partnership with a direct lender, or lends from its own balance sheet, it may be part of the private loan itself. - Lending to the lender: the bank may provide back leverage or fund finance to the direct lending fund that holds the loan. - The next mandates: add-on acquisitions, a later refinancing into the syndicated market once the company has grown and spreads have tightened, a dividend recap, and eventually the exit.

The coverage banker's job is to stay useful through all of that. A sponsor values a bank that can deliver either market without changing the conversation, and the bank that helped it pick the right lender, even a direct lender, is well placed to propose the syndicated refinancing a few years later. Advice on the lender choice is only credible if the bank discloses its own interest and shows every offer on the same basis.

What is a hung deal, and how does a bank end up losing money on one?

A hung deal is an acquisition financing that the underwriting banks are bound to fund but cannot sell to investors at a price within their flex caps.

The bank loses money through this sequence:

1. At signing, the banks commit to fund the debt on agreed terms and agree a fee, often months before closing. 2. Before they can sell the debt, the market moves: spreads widen, rates rise or investors lose appetite for the sector. 3. The banks use their market flex, raising the margin or the discount, but the market needs more than the caps allow. 4. The acquisition still closes, because the banks gave a firm commitment with very limited conditions, and they must fund.

The banks then either sell the debt at a discount, taking a loss that their fees only partly offset, or hold it on their balance sheet, carrying it at market value, tying up capital and limits, and waiting for demand to return. Either way, the fee was fixed at signing while the exposure ran until the debt was sold.

A hung deal also affects the client. Debt sold at a deep discount sets the market price for the company's debt, which can raise the cost of its next financing. That is why commitment committees now focus on how long a commitment stays open, how wide the flex is and whether a direct lender can share the risk.

A bank underwrites a $2 billion buyout term loan and earns 2% in fees. Before it can sell the loan, markets weaken, and after using all its flex it can only sell the loan at 92. What is the bank's net result?

The bank's net result is a loss of about $120 million.

- Fees earned: 2% x $2 billion = $40 million - Loss on the sale: selling at 92 means an 8 point discount, so 8% x $2 billion = $160 million - Net: $40 million - $160 million = -$120 million

The fee was fixed at signing, while the exposure ran until the loan was sold, and the flex caps had already been used up, so every extra point of discount came out of the bank's capital. Banks in this position can instead hold the loan until demand returns, earning interest but carrying it at market value, which reduces earnings through markdowns and ties up capital and underwriting limits. Either way, this is why commitment committees size flex, commitment length and hold appetite so carefully before they sign.

What does a sponsors banker do for a portfolio company between the buyout and the exit?

During the hold, the sponsors banker keeps working on the company's capital structure and strategic options, and most of the work comes as amendments to documents the company already has.

- Refinancings and repricings: cutting the margin when the credit improves or markets tighten, and refinancing or extending debt before maturities get close. - Add-on financing: funding acquisitions through incremental capacity or delayed-draw loans in the existing credit agreement. - Dividend recaps: borrowing to return cash to the fund when the company can carry more debt. - Divestitures and add-ons: buyer lists for units the company wants to sell and targets for the platform to buy. - Hedging, revolvers and cash management through the bank's lending relationship. - Exit preparation: a standing view on timing and route, IPO readiness and terms that ease a later sale.

Most of these begin with an event rather than a request from the sponsor: a market window, a date in the documents such as the end of call protection or an approaching maturity, a step in the company's plan, or the fund's need for cash. The banker spots these through regular portfolio reviews with the sponsor and by tracking each company's debt documents and performance.

The client also changes after closing. The company's CFO and treasurer sign and pay, the sponsor approves from the board, often through its capital markets team, and the existing lenders have to approve anything the documents do not already permit, such as a repricing or a maturity extension, while incremental debt and dividends within the baskets need no consent. Every transaction during the hold also shapes what the eventual buyer inherits.

A portfolio company has an $800 million term loan at SOFR + 400 basis points, still inside a 101 soft-call period. It can reprice to SOFR + 325. What does it save a year, what does the repricing cost, and how long is the payback?

The company saves about $6 million a year, the repricing costs about $8 million, and the payback is roughly 16 months.

- Annual saving: 400 bp - 325 bp = 75 bp, and 0.75% x $800 million = $6 million a year - Cost: the 101 soft call means a 1% premium, so 1% x $800 million = $8 million, plus arranger and legal fees - Payback: $8 million / $6 million a year, or about 1.3 years

Because the premium takes more than a year to earn back, the decision depends on how much time is left in the soft-call period and how long the sponsor expects to keep the loan. If the protection ends in a few months, it is usually better to wait and reprice for free. If the company is likely to be sold or refinanced soon, the saving may never cover the premium. A repricing usually also restarts the soft-call period, which pushes back the date of the next free repricing.

When would you pitch a repricing rather than a full refinancing to a sponsor-owned company?

A repricing changes only the margin. It is an amendment to the existing credit agreement: lenders that accept the lower spread keep their loans, and those that refuse are repaid from replacement loans. It is quick and cheap and leaves the documents in place, so it fits when the credit has improved or the market has tightened but the maturity is still comfortable and the structure still works.

A full refinancing repays the debt and replaces it, so it can change the size, maturity, covenants and mix of loans and bonds. It fits when:

- a maturity is approaching, which a lower margin would not fix - the company has outgrown its structure, for example after add-ons, or should move from a private credit unitranche to the cheaper syndicated market - the sponsor wants to change terms, such as covenants or incremental capacity, or raise new money for a dividend or an acquisition

Before pitching either, I would check three things together:

1. The documents: when the soft call ends, any call schedule or make-whole on the bonds, and what any pricing grid already gives the company automatically. 2. The credit: lower leverage, higher earnings or an upgrade that justifies a lower spread. 3. The market: where the existing loan trades (above par signals holders would accept less) and where comparable new loans are clearing.

The fee on a repricing is small, but the timing matters a lot to the client, and the bank that runs it learns which lenders stayed in, which helps with the next financing.

What is a dividend recapitalization, and why would a sponsor do one instead of selling the company?

A dividend recapitalization is when a portfolio company raises new debt and uses the proceeds to pay a dividend to its owners. The fund gets cash back before any sale, while the company keeps the extra debt.

A sponsor might choose one over a sale because:

- Upside kept: the sponsor keeps its whole stake and benefits if the plan keeps working, rather than selling at a price it thinks is too low. - A weak sale market: if buyers will not pay the sponsor's price, a recap returns cash without locking in a disappointing exit. - Distributions: LPs judge a fund heavily on cash returned (DPI), especially before the next fundraise, and a recap delivers cash within weeks. - Higher IRR: getting cash back earlier lifts the IRR, while the MOIC stays about flat or slips slightly once the extra interest is paid. - Spare debt capacity: a business that has grown and paid down debt since the buyout can borrow more.

The trade-off is risk. A recap adds leverage and interest, shrinks the equity cushion under the lenders and uses debt capacity the company might later need for add-ons or a downturn. Some LPs also discount distributions funded with borrowed money compared with cash from a real exit, because the risk stays with the fund.

A sponsor asks whether one of its portfolio companies can do a dividend recap. What would you look at before saying yes?

I would look at four things, and the tightest of them sets how big the dividend can be.

1. The company's credit: stable cash flow, leverage well below where it was at entry, and earnings that will hold up. Then I would size the debt: the leverage lenders will accept today, interest coverage after the new interest cost, and the equity cushion left under the debt, since the cash leaves the company the day the loan funds. 2. The documents: whether the existing credit agreement has room to borrow more (incremental capacity) and room to pay it out (the restricted payments baskets). If not, the choice is an amendment with a consent fee, a full refinancing, or debt raised above the operating company, such as holdco PIK notes. 3. The market: whether new loans are clearing near par and investors are open to deals that fund a payout, since lenders usually ask for a wider spread, a discount and tighter limits on further distributions. 4. The fund: why it wants cash now, whether a sale at a good price is close, and how the proceeds would flow through the fund's waterfall, including whether they would trigger carried interest.

There is also the legal side. The board needs to be comfortable that the company stays solvent after the payment, usually with an independent solvency opinion that counts contingent liabilities, because a company that later fails can face fraudulent-transfer claims to recover the dividend. My recommendation would lead with the cushion left behind, not the size of the dividend.

A portfolio company earns $150 million of EBITDA and has $450 million of net debt. Lenders will go to 5.0x. In year two the sponsor, which invested $500 million, recaps to that level and pays out the proceeds; without the recap it expected $1 billion of equity at a year-five exit. Ignoring fees and the extra interest, how big is the dividend, and what happens to the sponsor's MOIC and IRR?

The dividend is $300 million, the MOIC stays at about 2.0x, and the IRR rises.

Size: 5.0 x $150 million = $750 million of debt allowed, against $450 million today (3.0x), so the company can borrow $300 million more and pay it out.

Returns:

- Without the recap: $500 million grows to $1,000 million at the year-five exit, 2.0x, an IRR of about 15%. - With the recap: the sponsor receives $300 million in year two. The company now carries $300 million more debt, so the exit equity falls to $700 million. Total proceeds are $300 million + $700 million = $1,000 million, still 2.0x. - IRR: the same dollars arrive earlier, so the IRR rises: with 60% of the equity invested already back in year two, it moves from about 15% toward 20%, and the exact figure is about 19%.

In practice the MOIC slips slightly below 2.0x, because the extra debt costs interest for three years and the recap carries fees and a discount. The trade is a higher IRR and earlier DPI for the fund in exchange for more risk in the company. That is why a recap looks best on IRR and why some LPs discount it compared with cash from a sale.

A platform earns $100 million of EBITDA with $450 million of net debt. It buys an add-on with $20 million of EBITDA at 6x, funded entirely with debt. What is pro forma leverage, and what multiple would have left leverage unchanged?

Pro forma leverage rises to 4.75x, and buying at 4.5x would have kept it unchanged.

- Price of the add-on: 6 x $20 million = $120 million, all funded with debt - New debt: $450 million + $120 million = $570 million - New EBITDA: $100 million + $20 million = $120 million - Pro forma leverage: $570 million / $120 million = 4.75x, up from 4.5x

An add-on funded entirely with debt raises leverage when its purchase multiple is above the platform's leverage multiple and lowers it when the multiple is below. At 4.5x, the add-on would cost $90 million, and $540 million / $120 million = 4.5x.

That matters for the financing. Credit agreements usually test incremental debt on pro forma EBITDA including the target, so the add-on brings its own borrowing capacity. Many agreements also allow acquisition debt as long as it does not increase leverage. If the add-on is priced above that level, the gap has to come from cash, from the remaining incremental room or from new sponsor equity. And if lenders credit synergies in pro forma EBITDA, leverage looks lower on their definition than on reported earnings.

How can a sponsor-owned company finance an add-on acquisition, and why might the sponsor set up a delayed-draw term loan at the time of the buyout?

There are four main routes, which trade certainty against cost:

1. Add to the existing term loan using incremental room negotiated at the buyout. It is cheap and simple if investors will buy more of the same loan, but the room is only a permission: no lender has to provide it, and if the market wants a wider margin, the most favored nation clause may raise the price of the existing loan too. 2. A delayed-draw term loan (DDTL) committed at the buyout, which the company can draw during an agreed period for acquisitions. The money is committed, subject to draw conditions such as a leverage test, in exchange for a ticking fee on the undrawn amount. 3. A new incremental tranche on whatever terms the market sets when the target appears. 4. A full refinancing, when the add-on outgrows the existing documents.

A sponsor sets up a DDTL at the buyout when it can already see a pipeline of add-ons in the next year or two. Committed funding means the platform can sign deals quickly and with certainty, often with a limited condition acquisition provision that tests leverage when the purchase agreement is signed rather than when it closes. It also locks in capacity while lenders are competing hard for the buyout. The ticking fee makes it cheap insurance for a real, near pipeline and an expensive option on one that never appears.

The banker's job at entry is to size this capacity against the acquisition plan, so later add-ons can be done inside the agreement rather than through a new financing.

A portfolio company earns $120 million of EBITDA and has $600 million of floating-rate debt at an 8% all-in rate, with a maintenance covenant capping leverage at 6.0x. If EBITDA falls 20% and rates rise 100 basis points, what happens to leverage, interest coverage and the covenant?

Leverage rises from 5.0x to 6.25x, which breaches the 6.0x covenant, and interest coverage falls from 2.5x to about 1.8x.

Today:

- Leverage: $600 million / $120 million = 5.0x - Interest: 8% x $600 million = $48 million, so coverage is $120 million / $48 million = 2.5x

After the shock:

- EBITDA: $120 million x 0.8 = $96 million - Leverage: $600 million / $96 million = 6.25x, above the 6.0x maximum - Interest: 9% x $600 million = $54 million, so coverage is $96 million / $54 million, about 1.8x

Two things happen at once: the lower EBITDA pushes leverage up, and the higher rate on floating-rate debt takes more cash. The company is in breach even though it has not borrowed anything new, and it has less cash to fix the problem. The sponsor's options include an equity cure if the documents allow one, asking lenders for a waiver or reset (usually for a fee and a higher margin), or paying down debt with cash. In practice, interest rate hedges would soften the rate effect. This is the kind of test a banker runs between portfolio reviews to spot stress early.

A credit agreement caps leverage at 5.0x. The company has $440 million of debt and $80 million of LTM EBITDA. How much equity does the sponsor need to cure the breach if the cure must repay debt, and how much if the agreement lets the cure count as EBITDA?

Today the company is at 5.5x ($440 million / $80 million). To get back to 5.0x:

- If the cure repays debt: debt must fall to 5.0 x $80 million = $400 million, so the sponsor injects $40 million. - If the cure counts as EBITDA: EBITDA must rise to $440 million / 5.0 = $88 million, so the sponsor injects only $8 million.

The difference is large because an EBITDA cure is multiplied by the leverage ratio: each dollar of equity counts as a dollar of earnings, which supports five dollars of debt at a 5.0x test. A cure that repays debt only removes debt dollar for dollar.

That is why lenders limit EBITDA cures. Agreements usually cap how often a cure can be used (for example, not in consecutive quarters and only a few times over the life of the loan), cap the amount, and often say the cure counts only for the covenant test, not for other baskets or pricing. A cure also only buys time: the amount stays in the trailing EBITDA for the next few tests, but it is sized for today's shortfall, so if earnings keep falling the company breaches again, and the number of cures is capped. If the business keeps weakening, the sponsor faces the bigger decision of whether to put in real new equity or negotiate with its lenders.

A portfolio company is about to breach its leverage covenant. What are the sponsor's options, and how does it decide whether to put in more money?

The sponsor's options range from spending more of its own money to spending none:

1. Equity cure: inject equity that counts toward the covenant test, within the caps in the documents. This buys time, not a solution. 2. New equity: a larger check, as common or preferred equity, to pay down debt and fund the plan. 3. Amendment or waiver: lenders reset or waive the test in exchange for fees, a higher margin and often new sponsor equity. An amend-and-extend can also push out maturities. 4. Liability management transaction: using room in the documents to raise new debt or extend maturities with a majority of lenders, often at the expense of the others. It keeps the equity alive but costs goodwill with lenders the sponsor will need again. 5. A sale under stress, or handing the company to its lenders, usually in exchange for releases.

The decision turns on a few questions:

- Whether the equity is worth backing: equity in a company worth less than its debt still has option value if the business can recover. New money buys time, so it makes sense only if the sponsor genuinely believes in the recovery case. - What the fund can afford: A fund near the end of its life may have little reserve capital left, and putting a newer fund's money into an older fund's company creates a conflict between two groups of LPs. - Relationships: sponsors borrow from the same lenders across many companies, so an aggressive tactic can raise the cost of every future financing, while a record of support makes lenders more willing to help.

Handing over the keys does not mean the business has failed: it usually keeps operating with less debt. The sponsor has decided that staying the owner is no longer worth the price.

What exit routes does a sponsor have, and how does it choose between them?

A sponsor has five main exit routes:

- Sale to a strategic buyer: often the highest price, because the buyer can pay for synergies, and usually a clean exit in cash, but it can take longer and carry antitrust risk. - Sale to another sponsor (secondary buyout): quicker and more certain, especially with committed debt, but the price depends on how much the buyer can borrow. - IPO: keeps upside and sets a public price, but it is a partial exit. The sponsor sells only part of its stake at listing and the rest through sell-downs after the lock-up, typically over two to three years and sometimes longer. - Partial sale or minority stake: returns some cash and keeps control and upside, in exchange for rights given to the new investor. - Continuation vehicle: the sponsor sells the company from an older fund to a new vehicle it also manages, keeping the asset while giving existing investors the option of cash.

A dividend recap returns cash without being an exit.

The choice has two parts. First, whether to sell now or hold: holding only makes sense if the expected return on today's sale value beats what the fund could earn elsewhere. Second, which route, which depends on:

- the asset: whether the plan has been delivered and the next owner's thesis is visible - the fund: its age, its need for distributions and the next fundraise - the market: which buyers are active, how much debt sponsor buyers can raise, and whether the IPO window is open - the sponsor's priorities: maximum cash, certainty, speed, or keeping upside

Sponsors often keep two routes open at once, such as a dual-track IPO and sale, to test which delivers more.

A sponsor can sell a company now, three years in, at 2.0x its money, or hold two more years and expect 2.5x. How do the IRRs compare, and what return is it earning on the extra two years?

Selling now gives about 26%, holding gives about 20%, and the extra two years earn only about 12% a year.

- Sell now: 2.0x in three years is an IRR of about 26%. - Hold: 2.5x in five years is an IRR of about 20%. - Return on the extra two years: by holding, the sponsor is effectively reinvesting today's value of 2.0x to get 2.5x two years later. That is 2.5 / 2.0 = 1.25x over two years, or about 12% a year.

The multiple goes up by holding, which is why deal teams arguing from MOIC often want to wait. The more useful test is the return on the value the sponsor could realize today. Here it is about 12% a year, well below the 20% or more a buyout fund targets on new deals, so selling looks better unless the sponsor is confident the higher value is likely, or that a better buyer only appears once the plan is delivered.

Two more points push toward selling now: cash returned raises the fund's DPI, which matters for the next fundraise, and the 2.5x is an expectation, not a certainty. A sponsor already past its hurdle might still hold for the extra carry dollars, but its LPs would usually prefer the cash.

Walk me through selling a sponsor-owned company to a strategic buyer. What does a sponsor seller push for that a founder might not?

The sale itself follows a normal sell-side process: preparation, a buyer list, first and second rounds, and a negotiated purchase agreement. The difference is that a sponsor seller is selling for a fund that has to return cash to its LPs and eventually wind up, so it pushes for terms a founder might not insist on:

- All cash at one closing: no earn-out and no payment in the buyer's shares, because the fund wants to distribute the proceeds and close the investment. - No exposure after closing: representations that expire at closing, with the buyer relying on warranty and indemnity insurance instead of a large escrow. A big escrow is a distribution delayed. - Certainty of closing: a strong antitrust efforts covenant and a reverse termination fee if regulators block the deal, because strategic buyers in the same industry face the toughest antitrust review. - A firm timetable, with a clear outside date.

The seller also has to win the buyer's trust. Corporate buyers are wary of sponsor-owned assets: aggressive EBITDA add-backs, investment cut back late in the hold, management equity that pays out at closing, and a capital structure built for leverage. A good sell-side process answers those concerns early, with a quality of earnings report and vendor due diligence.

Finally, the seller's bank prepares a synergy case that shows each buyer what the business is worth inside its own company. A seller only collects the synergies the buyer believes, and a competing sponsor bid sets the floor that forces the buyer to share them.

Why would a sponsor buy a company from another sponsor, and how can it still make a return?

A sponsor sells to another sponsor for the usual reasons to sell: its plan is largely delivered, its fund needs cash, and today's price beats the expected return on holding. The asset also tends to suit financial buyers: steady cash flow, debt lenders will finance and no obvious corporate acquirer. A sponsor buyer offers the seller speed and certainty: few antitrust issues, committed equity and debt, a familiar process and continuity for management.

The harder question is why the buyer expects a return, since it is paying a price an informed seller accepted. The answer has to be a different plan, something the second owner can do that the first could not:

- Scale and add-ons: lead a bigger consolidation than the first fund could finance, with targets the seller did not buy. - New skills or strategy: pricing, operations, a product shift or sector expertise the first owner lacked. - International expansion through the buyer's network. - More leverage: the company's cash flow may support more debt than the seller used. This is the most criticized thesis, because it adds no operating value.

The catch is that the easy gains may already be taken: costs cut, cheap add-ons bought, and any multiple expansion already collected by the first owner. So the second owner usually has to grow earnings faster than the first did. The evidence is mixed: secondary buyouts made early in a fund's investment period perform about as well as other buyouts, but those made late, under pressure to deploy capital, tend to do worse and pull the average down.

A sponsor buys a company from another sponsor at 10x $150 million of EBITDA, with 6.0x leverage. It wants 2.5x its money in five years, expects to exit at 10x and to repay $300 million of debt. What EBITDA does it need at the exit?

The buyer needs about $210 million of EBITDA at the exit, 40% more than today.

- Entry: 10 x $150 million = $1,500 million, funded with 6.0 x $150 million = $900 million of debt and $600 million of equity. - Equity needed at exit: 2.5 x $600 million = $1,500 million. - Debt at exit: $900 million - $300 million = $600 million. - Enterprise value needed: $1,500 million + $600 million = $2,100 million. - EBITDA needed: $2,100 million / 10 = $210 million.

That is 40% growth over five years, roughly 7% a year, with no help from the multiple. If the exit multiple fell to 9x, the buyer would need about $233 million of EBITDA ($2,100 million / 9), more than 50% growth.

This is the core question in a secondary buyout: the second owner pays a price that already reflects the first owner's work, so its return has to come mainly from new earnings growth and debt paydown, not from buying cheaply or expecting the multiple to rise.

A sponsor invested $500 million. Three years later the company lists and the sponsor's stake is worth $1.5 billion; it sells a third at the IPO and a third in each of the next two years at the same price. What are its MOIC and IRR, compared with selling everything in year three?

The MOIC is 3.0x either way, but selling in installments cuts the IRR from about 44% to about 32.5%.

- Full sale in year three: the stake triples in three years, an IRR of about 44%. - Sale in thirds: $500 million comes back in each of years three, four and five. The total is still $1.5 billion, so the MOIC stays at 3.0x, but the cash arrives on average in year four. That is close to tripling in four years: roughly 30% as a quick estimate, 32.5% exactly.

An IPO is therefore the start of a sponsor's exit, not the exit itself: the listing prices the stake, and every year spent selling it down costs IRR, even at a flat share price.

Why would a sponsor sell a minority stake in a portfolio company instead of selling it outright, and what will the new investor ask for in return?

A sponsor sells a minority stake when it wants cash without giving up the company. Usually the motive is the fund: the deal team believes the plan has years to run, but the fund needs distributions for its LPs, is too concentrated in one company that has grown large, or needs to show realized cash before its next fundraise. Selling a slice settles part of the hold-or-sell decision at today's price and keeps the rest invested. It also sets a tested price that supports the mark on the stake the sponsor keeps.

The stake can be common shares, which share all outcomes pro rata, or a preferred security with a priority return, which is cheaper for the sponsor only if the company grows fast.

In return, the new investor protects itself by contract, because it cannot control the company or choose the exit:

- A board seat and information rights - Consent rights over new debt above a threshold, large acquisitions, senior share issues, dividends and dealings with the sponsor's other funds - Tag-along rights to join any sale, and limits on being dragged along below a minimum price - Sometimes a put right to sell its shares back after a period, or a deadline by which the company must be sold or listed

Each right narrows the sponsor's control, especially over timing. A put or a listing deadline can force the full exit the partial sale was meant to delay. A minority investor will usually also price in some discount for its lack of control, unless the asset is scarce enough to command a premium.

Why can buyout volumes fall sharply when financing costs rise, even though purchase multiples barely move?

Because when financing costs rise, buyers' bids fall straight away but sellers' asking prices do not, so the gap shows up as fewer deals rather than lower prices.

A sponsor's maximum bid is roughly the debt lenders will provide plus the equity its return target allows. When rates and credit spreads rise, the same company supports less debt at a higher cost, so either the sponsor writes a larger equity check or its bid falls. Buyers adjust immediately.

Sellers adjust slowly. A private owner remembers what it paid and the value it has marked the company at, and it can usually wait. Selling below that mark would lock in a weaker result and hurt its next fundraise. So the bid-ask spread widens: deals that cannot bridge it simply do not happen. Purchase multiples on the deals that do close barely move, because the deals that do close are mostly high-quality assets that can still support a full price.

Volume recovers when the gap closes from either side. Financing gets cheaper again, sellers become more willing because their funds need distributions, or buyers stretch because they need to deploy capital before their investment period ends. For banks, the mix of work shifts during the slow phase: fewer large acquisition financings and sale mandates, and more amendments, refinancings, add-on financings and private credit deals.